Northwind is excited to announce the addition of Alan Jay Payne as our new Director, Quality, Compliance, and Packaging! Jay Payne brings over 40 years of regulatory compliance expertise to Northwind Pharmaceuticals. Joining us most recently from Zimmer, Jay’s experience spans a wide array of compliance and quality positions at premier medical device and pharmaceutical organizations. Jay brings specific expertise in FDA 21CFR compliance, ISO quality systems, DEA controlled substance regulations, and cGMP (Current Good Manufacturing Practice) requirements. Welcome aboard Jay!!
New Drugs to Market – October Update
Phillip Berry | Oct 25th, 2024
The Food and Drug Administration (FDA) approved three novel drug therapies in October. One of those therapies, Hympavzi (marstacimab-hncq), is a medication indicated for the treatment of patients with Hemophilia A and Hemophilia B. Hympavzi utilizes a new pathway to help reduce the risk of bleeding episodes in patients with Hemophilia, a disease that impacts … more »